Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study

Publisher： Karger

E-ISSN： 1423-0232|81|2|104-112

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.2, 2011-10, pp. : 104-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

By  

Oncology Research and Treatment, Vol. 28, Iss. 6-7, 2005-06 ,pp. : 347-350

Karger

Access to resources Recommend Favorite

Cell proliferation, measured as flow cytometric S‐phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population‐based study

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 10, 2015-10 ,pp. : 1064-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cell proliferation, measured as flow cytometric S‐phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population‐based study

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 1-6349, Iss. 10, 2015-10 ,pp. : 1064-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of Adjuvant FOLFOX Regimens in Stage III Colorectal Cancer Patients: Retrospective Analysis of 667 Patients

By  

Oncology, Vol. 84, Iss. 4, 2013-02 ,pp. : 240-245

Karger

Access to resources Recommend Favorite

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite